Learn about CVE-2023-38956, a path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 that allows unauthenticated attackers to read arbitrary files. Find out impacts, technical details, and mitigation steps.
A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.
Understanding CVE-2023-38956
This section provides detailed information about CVE-2023-38956.
What is CVE-2023-38956?
CVE-2023-38956 is a path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 that enables unauthenticated attackers to access and read arbitrary files by providing a specially crafted payload.
The Impact of CVE-2023-38956
The exploitation of this vulnerability can lead to unauthorized access to sensitive information stored on the affected system, potentially exposing critical data to malicious actors.
Technical Details of CVE-2023-38956
In this section, we delve into the technical aspects of CVE-2023-38956.
Vulnerability Description
The vulnerability arises from improper input validation in ZKTeco BioAccess IVS v3.3.1, allowing attackers to manipulate file paths and access files outside the intended directories.
Affected Systems and Versions
The path traversal vulnerability impacts ZKTeco BioAccess IVS version 3.3.1. Other versions may also be susceptible if the same input validation issue exists.
Exploitation Mechanism
Exploiting CVE-2023-38956 involves sending a specially crafted payload to the application, tricking it into accessing files beyond its intended scope.
Mitigation and Prevention
This section outlines steps to mitigate and prevent the exploitation of CVE-2023-38956.
Immediate Steps to Take
Long-Term Security Practices
Patching and Updates
Stay informed about security advisories from ZKTeco and promptly apply patches and updates to ensure the ongoing security of your systems.